B.R. Slaap

498 total citations
16 papers, 364 citations indexed

About

B.R. Slaap is a scholar working on Experimental and Cognitive Psychology, Clinical Psychology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, B.R. Slaap has authored 16 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Experimental and Cognitive Psychology, 9 papers in Clinical Psychology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in B.R. Slaap's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (14 papers), Mental Health Research Topics (9 papers) and Child and Adolescent Psychosocial and Emotional Development (6 papers). B.R. Slaap is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (14 papers), Mental Health Research Topics (9 papers) and Child and Adolescent Psychosocial and Emotional Development (6 papers). B.R. Slaap collaborates with scholars based in Netherlands, United States and Austria. B.R. Slaap's co-authors include Johan A. den Boer, Fokko J. Bosker, H.G.M. Westenberg, Irene M. van Vliet, G D Burrows, W. Wolfgang Fleischhacker, H.G.M. Westenberg, Richard van Dyck, S. Visser and Wiljo J.P.J. van Hout and has published in prestigious journals such as Journal of Affective Disorders, Psychopharmacology and Acta Psychiatrica Scandinavica.

In The Last Decade

B.R. Slaap

15 papers receiving 347 citations

Peers

B.R. Slaap

ECP

CP

CMN

PMH

MB

Dennis L. Murphy United States

Innar Tõru Estonia

Oren Kalus United States

J.L. Rausch United States

George N.M. Gurguis United States

Alessandra Benedetti Italy

Cynthia D. Delmo Germany

Michel Schittecatte Netherlands

J. Massana Spain

Laurence Guttmacher United States

Dennis L. Murphy United States

B.R. Slaap

99 ×0.6

ECP

201 ×1.6

CP

195 ×1.7

CMN

70 ×0.8

PMH

74 ×1.2

MB

Citations per year, relative to B.R. Slaap B.R. Slaap (= 1×) peers Dennis L. Murphy

Countries citing papers authored by B.R. Slaap

Since Specialization

Citations

This map shows the geographic impact of B.R. Slaap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.R. Slaap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.R. Slaap more than expected).

Fields of papers citing papers by B.R. Slaap

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.R. Slaap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.R. Slaap. The network helps show where B.R. Slaap may publish in the future.

Co-authorship network of co-authors of B.R. Slaap

This figure shows the co-authorship network connecting the top 25 collaborators of B.R. Slaap. A scholar is included among the top collaborators of B.R. Slaap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.R. Slaap. B.R. Slaap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Hout, Wiljo J.P.J. van, Mark Huisman, B.R. Slaap, et al.. (2008). Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia. Acta Psychiatrica Scandinavica. 117(4). 260–270. 45 indexed citations

2.

Slaap, B.R., et al.. (2002). Heart rate variability as predictor of nonresponse to mirtazapine in panic disorder: a preliminary study. International Clinical Psychopharmacology. 17(2). 69–74. 16 indexed citations

3.

Slaap, B.R., et al.. (2001). The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period. International Clinical Psychopharmacology. 16(6). 363–368. 31 indexed citations

4.

Slaap, B.R. & Johan A. den Boer. (2001). The prediction of nonresponse to pharmacotherapy in panic disorder: A review. Depression and Anxiety. 14(2). 112–122. 67 indexed citations

5.

Boer, Johan A. den, Fokko J. Bosker, & B.R. Slaap. (2000). Serotonergic drugs in the treatment of depressive and anxiety disorders. Human Psychopharmacology Clinical and Experimental. 15(5). 315–336. 46 indexed citations

6.

Boer, Johan A. den, Fokko J. Bosker, & B.R. Slaap. (1999). Neurobiology of social anxiety disorder. European Neuropsychopharmacology. 9. 165–166. 1 indexed citations

7.

Boer, Johan A. den & B.R. Slaap. (1998). Review of current treatment in panicc disorder. International Clinical Psychopharmacology. 13. S25–S30. 22 indexed citations

8.

Westenberg, H.G.M., et al.. (1996). Pentagastrin has panic-inducing properties in obsessive compulsive disorder. Psychopharmacology. 126(4). 339–344. 17 indexed citations

9.

Slaap, B.R., Irene M. van Vliet, H.G.M. Westenberg, & Johan A. den Boer. (1996). MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. Psychopharmacology. 127(4). 353–358. 7 indexed citations

10.

Vliet, Irene M. van, B.R. Slaap, H.G.M. Westenberg, & Johan A. den Boer. (1996). Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder. European Neuropsychopharmacology. 6(2). 103–110. 20 indexed citations

11.

Slaap, B.R., Irene M. van Vliet, H.G.M. Westenberg, & Johan A. den Boer. (1996). MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. Psychopharmacology. 127(1-2). 353–358. 8 indexed citations

12.

Slaap, B.R., Irene M. van Vliet, H.G.M. Westenberg, & Johan A. den Boer. (1996). The prediction of response in the anxiety disorders. Acta Neuropsychiatrica. 8(4). 102–104. 2 indexed citations

13.

Vliet, Irene M. van, Johan A. den Boer, & B.R. Slaap. (1996). A double-blind comparative study of fluvoxamine and brofaromine in panic disorder patients. European Neuropsychopharmacology. 6. 206–207.

14.

Slaap, B.R., et al.. (1995). Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia. Psychopharmacology. 121(3). 317–322. 71 indexed citations

15.

Slaap, B.R., Irene M. van Vliet, H.G.M. Westenberg, & Johan A. den Boer. (1995). Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report). Journal of Affective Disorders. 33(1). 31–38. 10 indexed citations

16.

Vliet, Irene M. van, Johan A. den Boer, B.R. Slaap, & H.G.M. Westenberg. (1994). Brofaromine versus fluvoxamine in panic disorder. European Neuropsychopharmacology. 4(3). 356–357. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact